Pharmacologic suppression of intimal hyperplasia: a dose-response suppression by enalapril.

@article{Petrik1995PharmacologicSO,
  title={Pharmacologic suppression of intimal hyperplasia: a dose-response suppression by enalapril.},
  author={P V Petrik and Michael J Law and Wesley S. Moore and Michael D. Colburn and William J. Qui{\~n}ones-Baldrich and Hugh A. Gelabert},
  journal={The American surgeon},
  year={1995},
  volume={61 10},
  pages={851-5}
}
Intimal hyperplasia is an exaggerated proliferative response to arterial intimal injury. A successful means of limiting this hyperplastic response would significantly improve patency rates of vascular reconstruction. Angiotensin-converting enzyme (ACE) inhibitors decrease the proliferation and synthetic function of vascular smooth muscle cells in vitro… CONTINUE READING